The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biodyn Share News (OBD)

Share Price Information for Oxford Biodyn (OBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.82
Bid: 7.80
Ask: 7.96
Change: 0.08 (1.03%)
Spread: 0.16 (2.051%)
Open: 7.80
High: 7.82
Low: 7.70
Prev. Close: 7.80
OBD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Uniphar takeover fails; Pearson notes redemption end

Fri, 16th Dec 2022 21:22

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Pearson PLC - London-based education publisher - Notes that Pearson Funding completed the redemption of its USD94.2 million principal amount outstanding of its 3.3% guaranteed notes due 2023 at a redemption price of USD1,003. The notes were guaranteed by Pearson PLC.

----------

Bank of Cyprus Holdings PLC - Nicosia-based lender - Extends the appointment of its group chief executive officer Panicos Nicolaou to December 31, 2026. Signs an amending agreement to his existing contract of employment which extends the period.

----------

Technology Minerals PLC - London-based company focused on creating a circular economy for battery metals - Draws down a GBP500,000 tranche from its GBP4.0 million convertible bond facility with Macquarie Bank Ltd and Atlas Capital Markets LLC.

----------

Anpario PLC - manufacturer of natural sustainable feed additives for animal health, nutrition and biosecurity - Receives an ISO 14001 certification. It is an internationally recognised standard for Environmental Management Systems. "We are pleased to have been accredited with ISO 14001 as this reflects our team's high operational standards which are focused on achieving our ambitious sustainability goals without negatively impacting our planet," Corporate Responsibility Director Karen Prior comments.

----------

Zanaga Iron Ore Company Ltd - iron ore exploration and development company - Completes the acquisition of a 50% plus one share interest in Jumelles Ltd. Appoints Peter Hill and Denis Weinstein to the board of the company.

----------

Redx Pharma PLC - Macclesfield, England-based clinical-stage biotechnology company focused on the treatment of cancer and fibrotic disease - Enters into a clinical trial collaboration and supply agreement with Merck & Co for the supply of Keytruda, or pembrolizumab, an antibody used in cancer immunotherapy. "We are delighted to enter into a collaboration agreement with MSD for our ongoing PORCUPINE2 study to evaluate RXC004 in combination with their anti-PD-1 therapy, pembrolizumab. Biliary cancer is a devastating disease that is heavily reliant on Wnt signalling, so we are keen to explore the potential of combining RXC004 with ICIs. Our hypothesis, based on the preclinical data we have generated, is that when combined, there may be a greater chance of the patients showing an immune response, which we hope will lead to improved outcomes," Chief Medical Officer Jane Robertson says.

----------

Bushveld Minerals Ltd - South Africa-focused vanadium producer and energy storage provider - Says that Jacqueline Musiitwa will stand down as an Independent Non-Executive Director from the company's board effective immediately.

----------

Oxford BioDynamics PLC - Oxford-based biotechnology firm focused on discovery and development of epigenetic biomarkers - Gets "encouraging" initial results from an interim analysis conducted for the Refine-ALS prospective trial. It is a prospective, multicenter study sponsored by Mitsubishi Tanabe Pharma America. It is designed to identify biomarkers that could serve as quantifiable, biological and non-clinical measures of Edaravone's pharmacodynamic effect in Amyotrophic Lateral Sclerosis, a progressive nervous system disease.

----------

Uniphar PLC - Dublin-based healthcare business focusing on pharmaceutical and medical technology manufacturers - Reports that the Irish Competition & Consumer Protection Commission has not cleared its proposed acquisition of Dublin-based healthcare services provider Navi Group. States that the transaction will now no longer proceed to completion, as a result. The acquisition was first announced in December 2021.

----------

Beowulf Mining PLC - Natural resource developer and explorer focused on the Nordic region - Says its two new licenses at the Vardar lead-zinc-silver trend in Kosovo extend the coverage of Vardar's Mitrovica and Shala exploration projects. Adds that the two licences contain prospective "carbonate host rocks along with Oligocene magmatic rocks."

"The district being explored in northern Kosovo is highly prospective, with abundant evidence of widespread lead-zinc-silver mineralisation, and the addition of these new licences to Vardar's portfolio is a further exciting development. The Vardar team continues to use state-of-the-art exploration methodologies in the process of identifying new opportunities and is maintaining a competitive first-mover advantage in the region," CEO Kurt Budge says.

----------

PetroNeft Resources PLC - Ireland-based, Russian-focused oil and gas exploration and production company - Says that it is continuing to be in negotiations with Petrogrand AB regarding its loan facility. The facility has a current redemption value of USD2.5 million and matured on Thursday. "We cannot predict the outcome of these negotiations and the company will make further announcements in due course," the company states. In 2020 and 2021, PetroNeft extended its loan facility with Swedish firm Petrogrand AB.

----------

By Abby Amoakuh, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
3 Apr 2024 14:31

Oxford BioDynamics reaches "important milestone" with new laboratory

(Alliance News) - Oxford BioDynamics PLC said on Wednesday that it has opened a clinical testing laboratory in the UK to perform EpiSwitch prostate screening tests.

Read more
14 Mar 2024 16:53

TRADING UPDATES: FireAngel CFO resigns; ECR Minerals raises GBP585,000

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
13 Mar 2024 20:49

EARNINGS AND TRADING: PensionBee nears profit; OptiBiotix Indian deal

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
17 Jan 2024 10:50

CORRECT: Oxford BioDynamics plunges as annual loss widens; revenue up

(Correcting headline to show loss widened, revenue rose)

Read more
17 Jan 2024 10:43

CORRECT: Oxford BioDynamics plunge as annual profit rises; revenue up

(Correcting headline to show profit and revenue rose)

Read more
17 Jan 2024 10:35

Oxford BioDynamics shares plunge as annual revenue widens; revenue up

(Alliance News) - Oxford BioDynamics PLC on Wednesday said its full-year loss narrowed, but saw its revenue jump on contracts for EpiSwitch.

Read more
17 Jan 2024 10:24

AIM WINNERS & LOSERS: James Cropper falls on lower outlook

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
20 Oct 2023 15:32

Director dealings: Oxford Biodynamics director lowers stake

(Sharecast News) - Oxford Biodynamics revealed on Friday that Vulpes Testudo Fund had offloaded 777,000 ordinary shares in the AIM-listed biotechnology company.

Read more
20 Oct 2023 10:32

IN BRIEF: Oxford BioDynamics director sells over 700,000 shares

Oxford BioDynamics PLC - biotechnology company developing precision medicine tests based on the EpiSwitch 3D genomics platform - Reports that Vulpes Testudo Fund, controlled by Non-Executive Director Stephen Diggle has sold 777,000 shares of one pence each at an average price of 38.3p each. Diggle is now interested in 27.6 million shares in total, through the Vulpes Testudo and Vulpes Life Sciences Funds. These represent approximately 13.62% of Oxford BioDynamics's current issued share capital. Company's market capitalisation is GBP69.79 million.

Read more
18 Oct 2023 10:25

Oxford BioDynamics in deal with Bupa to expand blood test access

(Alliance News) - Oxford BioDynamics PLC shares surged on Wednesday as it announced a strategic deal with Bupa UK Insurance to enhance access to a "first-of-its-kind" blood test for cancer patients.

Read more
3 Oct 2023 10:41

Oxford BioDynamics secures US billing code for prostate test

(Sharecast News) - Precision test developer Oxford BioDynamics has successfully secured a proprietary laboratory analysis (PLA) code from the American Medical Association's (AMA) Current Procedural Terminology (CPT) Editorial Board, it announced on Tuesday.

Read more
3 Oct 2023 10:21

AIM WINNERS & LOSERS: Safestyle plunges as seeks cash injection

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
3 Oct 2023 10:15

Oxford BioDynamics issued insurance reimbursement code for EpiSwitch

(Alliance News) - Oxford BioDynamics PLC on Tuesday said it has been issued an insurance reimbursement code for its EpiSwitch product from the American Medical Association.

Read more
26 Sep 2023 17:41

Oxford BioDynamics soars as validates prostate test ahead of schedule

(Alliance News) - Shares in Oxford BioDynamics PLC leapt on Tuesday after it announced the validation of its EpiSwitch prostate screening test in its US clinical laboratory was now complete, ahead of schedule.

Read more
11 Aug 2023 15:44

UK shareholder meetings calendar - next 7 days

Monday 14 August 
Ethernity Networks LtdAGM
Nanoco Group PLCGM re change in the control of the company
Tuesday 15 August 
Castings PLCAGM
Momentum Multi-Asset Value Trust PLCGM re reconstruction and voluntary winding-up
Primorus Investments PLCAGM
WH Ireland Group PLCGM re dealings in the new ordinary shares
Wednesday 16 August 
Cadence Minerals PLCAGM
Calnex Solutions PLCAGM
NextEnergy Solar Fund LtdAGM
NFT Investments PLCAGM
StreaksAI PLCAGM
VSA Capital Group PLCAGM
Thursday 17 August 
Harvest Minerals LtdAGM
Quantum Exponential Group PLCAGM
Windward LtdAGM
Yourgene Health PLCGM and court meeting re takeover by Novacyt
Friday 18 August 
ME Group International PLCGM re proposed share buyback
Oxford BioDynamics PLCGM re placing
Pathfinder Minerals PLCGM re disposal of the subsidiary
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.